Caroline Aspord

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Clinical & translational immunology

International journal of molecular sciences

Immunology

Cancers

EFS Auvergne Rhône-Alpes / Institute for Advanced Biosciences - Research center UGA / Inserm 1209 / CNRS UMR 5309

Institut Pasteur (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

EFS Auvergne Rhône-Alpes / Institute for Advanced Biosciences - Research center UGA / Inserm 1209 / CNRS UMR 5309 Jan 01 2006

France

Research Investigator :: Immunobiology and Immunotherapy of chronic diseases

Baylor Institute for Immunology Research

United States

Post-doctoral fellow

Education History

Institut Pasteur

France

MSC

Publications

Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy. Immunology 173 (1) (2024)
Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy. Immunology (2024)
Dalil Hannani, Estelle Leplus, David Laurin, Benjamin Caulier, Caroline Aspord, Natacha Madelon, Ekaterina Bourova-Flin, Christian Brambilla, Elisabeth Brambilla, Anne-Claire Toffart, Karine Laulagnier, Laurence Chaperot, Joël Plumas
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15 (8) (2023)
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15 (8) (2023)
Dalil Hannani, Estelle Leplus, David Laurin, Benjamin Caulier, Caroline Aspord, Natacha Madelon, Ekaterina Bourova-Flin, Christian Brambilla, Elisabeth Brambilla, Anne-Claire Toffart, Karine Laulagnier, Laurence Chaperot, Joël Plumas
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Dalil Hannani, Estelle Leplus, David Laurin, Benjamin Caulier, Caroline Aspord, Natacha Madelon, Ekaterina Bourova-Flin, Christian Brambilla, Elisabeth Brambilla, Anne-Claire Toffart, Karine Laulagnier, Laurence Chaperot, Joël Plumas
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. International journal of molecular sciences 24 (3) (2023)
Camille Niveau, Eleonora Sosa Cuevas, Benoît Roubinet, Mylène Pezet, Michel Thépaut, Stéphane Mouret, Julie Charles, Franck Fieschi, Ludovic Landemarre, Laurence Chaperot, Philippe Saas, Caroline Aspord
Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding. Immunology (2023)
Jamila Kacher, Olivier Manches, Caroline Aspord, Hervé Sartelet, Laurence Chaperot
Impaired Antitumor Immune Response in MYCN -amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment. Cancer research communications 2 (7) (2022)
Solène Besson, David Laurin, Cyrielle Chauvière, Michel Thépaut, Jean-Philippe Kleman, Mylène Pezet, Olivier Manches, Franck Fieschi, Caroline Aspord, Pascal Fender
Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses. Biomedicines 10 (11) (2022)
Eleonora Sosa Cuevas, Nathalie Bendriss-Vermare, Stephane Mouret, Florence De Fraipont, Julie Charles, Jenny Valladeau-Guilemond, Laurence Chaperot, Caroline Aspord
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80 + PDL1 - )-pDC subset negatively correlated with clinical outcomes in melanoma patients. Clinical & translational immunology 11 (5) (2022)
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot, Caroline Aspord
Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & translational immunology 10 (11) (2021)
Laurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, Thomas Decaens, Jean-Baptiste Reiser, Eleonora Sosa Cuevas, David Durantel, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, Caroline Aspord
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs. Clinical & translational immunology 9 (12) (2020)
Eleonora Sosa Cuevas, Laurissa Ouaguia, Stephane Mouret, Julie Charles, Florence De Fraipont, Olivier Manches, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, Caroline Aspord
BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Clinical & translational immunology 9 (11) (2020)
Julie Charles, Stephane Mouret, Isabelle Challende, Marie-Therese Leccia, Florence De Fraipont, Solene Perez, Nadia Plantier, Joel Plumas, Manuarii Manuel, Laurence Chaperot, Caroline Aspord
T-cell receptor diversity as a prognostic biomarker in melanoma patients. Pigment cell & melanoma research 33 (4) (2020)
Julie Charles, Laurence Chaperot, Bruno Revol, Marine Baudin, Stephane Mouret, Agnes Hamon, Marie-Therese Leccia, Joel Plumas, Caroline Aspord
The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients. Pigment cell & melanoma research 31 (1) (2017)

Caroline Aspord.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Caroline Aspord